Gilbert J. Cote

10.1k total citations · 2 hit papers
141 papers, 7.3k citations indexed

About

Gilbert J. Cote is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Oncology. According to data from OpenAlex, Gilbert J. Cote has authored 141 papers receiving a total of 7.3k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Molecular Biology, 56 papers in Endocrinology, Diabetes and Metabolism and 39 papers in Oncology. Recurrent topics in Gilbert J. Cote's work include Thyroid Cancer Diagnosis and Treatment (42 papers), Neuroendocrine Tumor Research Advances (25 papers) and RNA Research and Splicing (24 papers). Gilbert J. Cote is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (42 papers), Neuroendocrine Tumor Research Advances (25 papers) and RNA Research and Splicing (24 papers). Gilbert J. Cote collaborates with scholars based in United States, China and Germany. Gilbert J. Cote's co-authors include Robert F. Gagel, Susan M. Berget, Barbara Robberson, Pamela M. Thomas, Nelson Wohllk, Camilo Jiménez, Nancy D. Perrier, Puthenpurackal M. Mathew, Douglas B. Evans and Steven G. Waguespack and has published in prestigious journals such as Science, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Gilbert J. Cote

138 papers receiving 7.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mutations in the Sulfonylurea Receptor Gene in Familial Persistent Hyperinsulinemic Hypoglycemia of Infancy

1995 632 citations Pamela M. Thomas, Gilbert J. Cote et al. profile →
Exon definition may facilitate splice site selection in RNAs with multiple exons.

1990 619 citations Gilbert J. Cote, Susan M. Berget et al. Molecular and Cellular Biology profile →

Peers

Countries citing papers authored by Gilbert J. Cote

Since Specialization

Citations

This map shows the geographic impact of Gilbert J. Cote's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gilbert J. Cote with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gilbert J. Cote more than expected).

Fields of papers citing papers by Gilbert J. Cote

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gilbert J. Cote. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gilbert J. Cote. The network helps show where Gilbert J. Cote may publish in the future.

Co-authorship network of co-authors of Gilbert J. Cote

This figure shows the co-authorship network connecting the top 25 collaborators of Gilbert J. Cote. A scholar is included among the top collaborators of Gilbert J. Cote based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gilbert J. Cote. Gilbert J. Cote is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impact of Somatic Mutations on Survival Outcomes in Patients With Anaplastic Thyroid Carcinoma 2022 ·JCO Precision Oncology ·Jennifer Wang, (unknown), Xu Li, Maitrayee Goswami, Xiao Zhao, Gilbert J. Cote, Wenyi Wang, Priyanka Iyer, Ramona Dadu, Naifa L. Busaidy, Stephen Y. Lai, Neil D. Gross, Renata Ferrarotto, Charles Lu, G. Brandon Gunn, Michelle D. Williams, Mark J. Routbort, Mark Zafereo, Maria E. Cabanillas	45
2	Hallmarks of RET and Co-occuring Genomic Alterations inRET-aberrant Cancers 2021 ·Molecular Cancer Therapeutics ·Jacob J. Adashek, Aakash Desai, Alexander Andreev-Drakhlin, Jason Roszik, Gilbert J. Cote, Vivek Subbiah	33
3	Clinical Utility of Circulating Cell-Free DNA Mutations in Anaplastic Thyroid Carcinoma 2021 ·Thyroid ·Yu Qin, Jennifer Wang, Ying Wang, Priyanka Iyer, Gilbert J. Cote, Naifa L. Busaidy, Ramona Dadu, Mark Zafereo, Michelle D. Williams, Renata Ferrarotto, G. Brandon Gunn, Peng Wei, Keyur P. Patel, Marie‐Claude Hofmann, Maria E. Cabanillas	34
4	Risk Haplotypes Uniquely Associated with Radioiodine-Refractory Thyroid Cancer Patients of High African Ancestry 2019 ·Thyroid ·(unknown), Sandya Liyanarachchi, Huiling He, Pamela Brock, Jennifer A. Sipos, Fadi Nabhan, Electron Kebebew, (unknown), Gilbert J. Cote, Steven I. Sherman, Christopher J. Walker, (unknown), Shuai Xue, (unknown), Wei Li, (unknown), (unknown), Albert de la Chapelle, Sissy Jhiang	14
5	Novel use of a Clinical Laboratory Improvements Amendments (CLIA)-certified Cyclin-Dependent Kinase N2C (CDKN2C) loss assay in sporadic medullary thyroid carcinoma 2019 ·Surgery ·Jessica E. Maxwell, Maria Gule-Monroe, Vivek Subbiah, Mimi I. Hu, Nancy D. Perrier, Maria E. Cabanillas, Jeffery E. Lee, Paul H. Graham, Gilbert J. Cote, Naifa L. Busaidy, Elizabeth G. Grubbs	8
6	Combinations of Tyrosine Kinase Inhibitor and ERAD Inhibitor Promote Oxidative Stress–Induced Apoptosis through ATF4 and KLF9 in Medullary Thyroid Cancer 2018 ·Molecular Cancer Research ·Rozita Bagheri‐Yarmand, Krishna M. Sinha, Ling Li, Yue Lu, Gilbert J. Cote, Steven I. Sherman, Robert F. Gagel	26
7	Parathyroid carcinoma and atypical parathyroid neoplasms in MEN1 patients; A clinico-pathologic challenge. The MD Anderson case series and review of the literature 2016 ·International Journal of Surgery ·Ioannis Christakis, Naifa L. Busaidy, Gilbert J. Cote, Michelle D. Williams, (unknown), Angelica M. Silva, (unknown), Callisia N. Clarke, Wei Qiu, Jeffrey E. Lee, Nancy D. Perrier	43
8	A splicing switch from ketohexokinase-C to ketohexokinase-A drives hepatocellular carcinoma formation 2016 ·Nature Cell Biology ·Xinjian Li, Xu Qian, Li-Xia Peng, Yuhui Jiang, David H. Hawke, Yanhua Zheng, Yan Xia, Jong-Ho Lee, Gilbert J. Cote, Hongxia Wang, Liwei Wang, Chao-Nan Qian, Zhimin Lu	139
9	Hepatocyte Growth Factor/cMET Pathway Activation Enhances Cancer Hallmarks in Adrenocortical Carcinoma 2015 ·Cancer Research ·Liem Phan, Enrique Fuentes‐Mattei, Weixin Wu, Guermarie Velázquez-Torres, Kanishka Sircar, Christopher G. Wood, Tao Hai, Camilo Jiménez, Gilbert J. Cote, (unknown), Marie‐Claude Hofmann, Siyuan Zheng, Roeland Verhaak, Lance C. Pagliaro, María Angélica Cortez, Mong‐Hong Lee, Sai‐Ching J. Yeung, Mouhammed Amir Habra	34
10	EGFR-Induced and PKCε Monoubiquitylation-Dependent NF-κB Activation Upregulates PKM2 Expression and Promotes Tumorigenesis 2012 ·Molecular Cell ·Weiwei Yang, Yan Xia, Yu Cao, Yanhua Zheng, Wen Bu, Lin Zhang, M. James You, Mei Yee Koh, Gilbert J. Cote, Kenneth Aldape, Yi Li, Inder M. Verma, Paul J. Chiao, Zhimin Lu	219
11	RNA splicing in regulation of nitric oxide receptor soluble guanylyl cyclase 2011 ·Nitric Oxide ·Iraida Sharina, Gilbert J. Cote, Emil Martin, Marie–Françoise Doursout, Ferid Murad	16
12	Achieving eugastrinemia in MEN1 patients: Both duodenal inspection and formal lymph node dissection are important 2011 ·Surgery ·Paxton V. Dickson, Thereasa A. Rich, Yan Xing, Gilbert J. Cote, Huamin Wang, Nancy D. Perrier, Douglas B. Evans, Jeffrey E. Lee, Elizabeth G. Grubbs	19
13	Inhibition of Y-box binding protein-1 slows the growth of glioblastoma multiforme and sensitizes to temozolomide independent O 6-methylguanine-DNA methyltransferase 2009 ·Molecular Cancer Therapeutics ·Yuanyuan Gao, Abbas Fotovati, Cathy Lee, Michelle Wang, Gilbert J. Cote, Emma S. Tomlinson Guns, Brian Toyota, Damien Faury, Nada Jabado, Sandra E. Dunn	45
14	Correction of aberrant FGFR1 alternative RNA splicing through targeting of intronic regulatory elements 2004 ·Human Molecular Genetics ·Ivone Bruno, Wei Jin, Gilbert J. Cote	70
15	A Novel Point Mutation of theRETProtooncogene Involving the Second Intracellular Tyrosine Kinase Domain in a Family with Medullary Thyroid Carcinoma 2004 ·The Journal of Clinical Endocrinology & Metabolism ·Camilo Jiménez, (unknown), Pamela N. Schultz, Adel K. El‐Naggar, Suzanne E. Shapiro, Elizabeth Barnes, Douglas B. Evans, Rena Vassilopoulou‐Sellin, Robert F. Gagel, Gilbert J. Cote, Ana O. Hoff	32
16	Inactivation of the first nucleotide-binding fold of the sulfonylurea receptor, and familial persistent hyperinsulinemic hypoglycemia of infancy. 1996 ·PubMed Central ·Pamela M. Thomas, Nelson Wohllk, Elbert S. Huang, Ursula Kuhnle, Wolfgang Rabl, Robert F. Gagel, Gilbert J. Cote	63
17	APPLICATION OF GENETIC SCREENING INFORMATION TO THE MANAGEMENT OF MEDULLARY THYROID CARCINOMA AND MULTIPLE ENDOCRINE NEOPLASIA TYPE 2 1996 ·Endocrinology and Metabolism Clinics of North America ·Nelson Wohllk, Gilbert J. Cote, Douglas B. Evans, Helmuth Goepfert, Nelson G. Ordóǹez, Robert F. Gagel	47
18	An Intron Enhancer Containing a 5′ Splice Site Sequence in the Human Calcitonin/Calcitonin Gene-Related Peptide Gene 1995 ·Molecular and Cellular Biology ·Hua Jane Lou, Yun Yang, Gilbert J. Cote, Susan M. Berget, Robert F. Gagel	63
19	Calcitonin Exon Sequences Influence Alternative RNA Processing 1990 ·Molecular Endocrinology ·Gilbert J. Cote, (unknown), Susan M. Berget, Robert F. Gagel	20
20	1,25-Dihydroxyvitamin D₃Silences 3′,5′-Cyclic Adenosine Monophosphate Enhancement of Somatostatin Gene Transcription in Human Thyroid C Cells 1989 ·Molecular Endocrinology ·Douglas G. Rogers, Gilbert J. Cote, (unknown), Robert F. Gagel	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact